| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alirocumab Has Greater Reduction of LDL-C Than Ezetimibe in Patients with Statin Intolerance
|
Nichols, Emma Hitt
|
|
2014
|
|
52 |
p. 16-17
|
artikel
|
| 2 |
Aspirin Fails to Reduce CVD in Elderly Japanese
|
Nichols, Emma Hitt
|
|
2014
|
|
52 |
p. 15-16
|
artikel
|
| 3 |
AVOID: Oxygen Use Damaging in STEMI
|
Hoyle, Brian
|
|
2014
|
|
52 |
p. 22-23
|
artikel
|
| 4 |
BASKET-PROVE II: BP-DES Noninferior to DP-DES
|
Hoyle, Brian
|
|
2014
|
|
52 |
p. 20-21
|
artikel
|
| 5 |
CABG Plus Valve Repair Provides No Benefit in MR over CABG Alone
|
Nichols, Emma Hitt
|
|
2014
|
|
52 |
p. 19-20
|
artikel
|
| 6 |
DAPT Study: Benefits Seen with Prolonged DAPT after DES Treatment
|
Cunningham, Muriel
|
|
2014
|
|
52 |
p. 14-15
|
artikel
|
| 7 |
Diabetes and HF: Nexus of 2 Epidemics
|
Mosley, Mary
|
|
2014
|
|
52 |
p. 33-35
|
artikel
|
| 8 |
ENGAGE AF-TIMI 48: Edoxaban Safe and Effective in Elderly Patients with AF
|
Mosley, Mary
|
|
2014
|
|
52 |
p. 25-26
|
artikel
|
| 9 |
Ezetimibe Plus Statin Reduces CV Events after ACS
|
Nichols, Emma Hitt
|
|
2014
|
|
52 |
p. 17-18
|
artikel
|
| 10 |
Genomics/Omics for Cardiovascular Disease Gene Discovery and Translation
|
Hoyle, Brian
|
|
2014
|
|
52 |
p. 8-9
|
artikel
|
| 11 |
ISAR-SAFE: No Difference in 6-Month vs 12-Month DAPT after DES
|
Cunningham, Muriel
|
|
2014
|
|
52 |
p. 13-14
|
artikel
|
| 12 |
ITALIC/ITALICplus: 12-Month Data Suggest 6 Months of DAPT is Noninferior to 24 Months of DAPT
|
Cunningham, Muriel
|
|
2014
|
|
52 |
p. 11-12
|
artikel
|
| 13 |
Losartan Lacks Benefit in Inherited HCM
|
Nichols, Emma Hitt
|
|
2014
|
|
52 |
p. 18-19
|
artikel
|
| 14 |
Management of AF Based on New Science and New Guidelines
|
Vinall, Maria
|
|
2014
|
|
52 |
p. 30-32
|
artikel
|
| 15 |
New Technologies and Big Data Provide Hope for the Future in Patient Care
|
Cunningham, Muriel
|
|
2014
|
|
52 |
p. 5-7
|
artikel
|
| 16 |
PARADIGM-HF: Disease Progression Slowed with Novel Drug
|
Mosley, Mary
|
|
2014
|
|
52 |
p. 23-24
|
artikel
|
| 17 |
Perspectives on the 2013 ACC/AHA Guidelines to Reduce CV Risk
|
Vinall, Maria
|
|
2014
|
|
52 |
p. 27-29
|
artikel
|
| 18 |
PreSERVE-AMI: CD34+ Cells Improve Cardiac Function, Reduce Events after STEMI
|
Mosley, Mary
|
|
2014
|
|
52 |
p. 24-25
|
artikel
|
| 19 |
SYNERGY Everolimus-Eluting Stent Noninferior to PROMUS Element Plus: Results from EVOLVE II Randomized Clinical Trial
|
Hoyle, Brian
|
|
2014
|
|
52 |
p. 21-22
|
artikel
|
| 20 |
TL-PAS Shows Reduction of Ischemic Events with Long-Term Prasugrel
|
Cunningham, Muriel
|
|
2014
|
|
52 |
p. 10-11
|
artikel
|
Tijdschrift beschrijving